Oculis Holding Ag (OCS)

May 27, 2025

Trend Tracker for (OCS) - news.stocktradersdaily.com

May 27, 2025

May 19, 2025

Trend Tracker for (OCSAW) - news.stocktradersdaily.com

May 19, 2025

May 15, 2025

HC Wainwright Estimates Oculis’ Q2 Earnings (NASDAQ:OCS) - Defense World

May 15, 2025

May 15, 2025

HC Wainwright Weighs in on Oculis’ Q1 Earnings (NASDAQ:OCS) - Defense World

May 15, 2025

May 13, 2025

Oculis (NASDAQ:OCS) Sees Large Volume Increase on Analyst Upgrade - Defense World

May 13, 2025

May 12, 2025

Oculis (NASDAQ:OCS) Price Target Raised to $33.00 - Defense World

May 12, 2025

May 09, 2025

Oculis Holding AG (OCS) Reports Q1 Loss, Tops Revenue Estimates - MSN

May 09, 2025

May 09, 2025

Oculis Announces 2025 Annual General Meeting Details - TipRanks

May 09, 2025

May 09, 2025

Oculis Publishes Invitation to the Annual General Meeting - The Manila Times

May 09, 2025

May 09, 2025

Dave To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Friday - Benzinga

May 09, 2025

May 09, 2025

Oculis Reports Q1 2025 Financial Results and Provides Company Update - The Manila Times

May 09, 2025

May 09, 2025

Oculis Holding AG Reports Strong Q1 Progress - TipRanks

May 09, 2025

May 09, 2025

Learn to Evaluate (OCSAW) using the Charts - news.stocktradersdaily.com

May 09, 2025

May 09, 2025

Earnings Preview: Oculis Holding AG (OCS) Q1 Earnings Expected to Decline - MSN

May 09, 2025

May 08, 2025

Oculis Holding AG reports results for the quarter ended March 31Earnings Summary - TradingView

May 08, 2025

May 08, 2025

Oculis Holding AG Reports Q1 2025 Financial Results - TipRanks

May 08, 2025

May 07, 2025

Oculis to Present at Upcoming May Investor Conferences - EIN News

May 07, 2025

May 07, 2025

REG-Oculis to Present at Upcoming May Investor Conferences - TradingView

May 07, 2025

May 06, 2025

Long Term Trading Analysis for (OCS) - news.stocktradersdaily.com

May 06, 2025

May 04, 2025

Oculis (NASDAQ:OCS) Sees Unusually-High Trading Volume – Still a Buy? - Defense World

May 04, 2025

May 04, 2025

Oculis Holding AG (NASDAQ:OCS) Shares Bought by Geode Capital Management LLC - Defense World

May 04, 2025

May 01, 2025

Oculis to Present its Innovative Late-Stage Pipeline Candidates at Upcoming Ophthalmology Conferences - The Manila Times

May 01, 2025

May 01, 2025

Oculis Holding AG to Present Innovative Late-Stage Pipeline at Major Ophthalmology Conferences in 2025 - Nasdaq

May 01, 2025

May 01, 2025

Oculis to Present its Innovative Late-Stage Pipeline Candidates at Upcoming Ophthalmology Conferences - GlobeNewswire Inc.

May 01, 2025

May 01, 2025

Oculis Holding AG to Present Innovative Late-Stage Pipeline at Major Ophthalmology Conferences in May 2025 - Nasdaq

May 01, 2025

Apr 26, 2025

Oculis Updates Share Capital - The Manila Times

Apr 26, 2025

Apr 23, 2025

Long Term Trading Analysis for (OCSAW) - news.stocktradersdaily.com

Apr 23, 2025

Apr 20, 2025

(OCS) Trading Advice - news.stocktradersdaily.com

Apr 20, 2025

Apr 19, 2025

Chardan Capital Reaffirms Buy Rating for Oculis (NASDAQ:OCS) - Defense World

Apr 19, 2025

Apr 19, 2025

HC Wainwright Increases Oculis (NASDAQ:OCS) Price Target to $32.00 - Defense World

Apr 19, 2025

Apr 18, 2025

Oculis (NASDAQ:OCS) Shares Gap Up Following Analyst Upgrade - Defense World

Apr 18, 2025

Apr 17, 2025

Oculis and EURETINA Announce the 2025 Ramin Tadayoni Award - The Manila Times

Apr 17, 2025

Apr 15, 2025

Stifel maintains Buy rating, $35 target on Oculis shares By Investing.com - Investing.com South Africa

Apr 15, 2025

Apr 15, 2025

Stifel maintains Buy rating, $35 target on Oculis shares - Investing.com

Apr 15, 2025

Apr 15, 2025

Oculis Holding AG Unveils Key Clinical Updates and Future Outlook at R&D Day - TipRanks

Apr 15, 2025

Apr 15, 2025

Oculis Hosts R&D Event Today to Showcase Progress on All Three Pipeline Assets - The Manila Times

Apr 15, 2025

Apr 11, 2025

Oculis completes enrolment in trials for diabetic macular oedema eye drops - Yahoo

Apr 11, 2025

Apr 10, 2025

Oculis completes enrollment for pivotal DME treatment trials By Investing.com - Investing.com South Africa

Apr 10, 2025

Apr 10, 2025

Oculis Completes Enrollment in Late-Stage Diabetic Macular Edema Trials - marketscreener.com

Apr 10, 2025

Apr 10, 2025

Oculis completes enrollment for pivotal DME treatment trials - Investing.com

Apr 10, 2025

Apr 10, 2025

Oculis Wraps Up Patient Enrollment in Late-stage Studies of Topical Eye Drug - MarketScreener

Apr 10, 2025

Apr 10, 2025

Oculis Completes Enrollment in both DIAMOND Phase 3 Trials of OCS-01 in Diabetic Macular Edema - The Manila Times

Apr 10, 2025

Apr 10, 2025

REG-Oculis Completes Enrollment in both DIAMOND Phase 3 Trials of OCS-01 in Diabetic Macular Edema - TradingView

Apr 10, 2025

Apr 04, 2025

(OCS) Trading Signals - news.stocktradersdaily.com

Apr 04, 2025

Apr 03, 2025

A First Look At Oculis Holding AG: Revenues Still Several Years Away (NASDAQ:OCS) - Seeking Alpha

Apr 03, 2025

Apr 01, 2025

Oculis to Host In-Person and Virtual R&D Day on Key Business Updates and the Development Plans for Privosegtor (OCS-05) in Acute Optic Neuritis and Beyond - The Manila Times

Apr 01, 2025